| 創建日期 | 上櫃日期 | 董事長 | 總經理 |
|---|---|---|---|
| 89/05/09 | 105/07/19 | 詹青柳 | 黃正谷 |
| EPS | 本益比 | 股價淨值比 | 現金殖利率 |
| -0.62(Q2) | 0 | 4.44 | 0% |
| 實收資本額 | 已發行普通股 | ||
| 3,395,698,910 | 339,569,891 | ||
| 主要經營業務 | |||
| 從事新藥之研究、開發、生產與銷售 | |||
| 公司網址 | |||
| pharmaessentia.com | |||
藥華藥(6446) 月營收報表
| 年度/月份 | 營業收入（單位：千元） | 累計營業收入（單位：千元） | |||||
|---|---|---|---|---|---|---|---|
| 單月營收 | 去年同月營收 | 單月月增率 | 單月年增率 | 累計營收 | 去年累計營收 | 累積年增率 | |
| 2023/08 | 458,657 | 207,200 | 2.9% | 121.3% | 3,056,944 | 1,785,158 | 71.2% |
| 2023/07 | 445,805 | 348,489 | -12.4% | 27.9% | 2,598,287 | 1,577,958 | 64.7% |
| 2023/06 | 509,165 | 276,669 | 21.7% | 84% | 2,152,482 | 1,229,469 | 75.1% |
| 2023/05 | 418,256 | 347,722 | 24% | 20.3% | 1,643,317 | 952,800 | 72.5% |
| 2023/04 | 337,413 | 353,334 | -2.9% | -4.5% | 1,225,061 | 605,078 | 102.5% |
| 2023/03 | 347,660 | 132,070 | 13% | 163.2% | 887,647 | 251,744 | 252.6% |
| 2023/02 | 307,618 | 55,023 | 32.4% | 459.1% | 539,988 | 119,674 | 351.2% |
| 2023/01 | 232,370 | 64,651 | -7.4% | 259.4% | 232,370 | 64,651 | 259.4% |
| 2022/12 | 250,922 | 111,793 | -20.6% | 124.4% | 2,882,042 | 656,043 | 339.3% |
| 2022/11 | 315,947 | 225,350 | 14.9% | 40.2% | 2,631,119 | 544,250 | 383.4% |
| 2022/10 | 274,863 | 42,398 | 7.7% | 548.3% | 2,315,172 | 318,900 | 626% |
| 2022/09 | 255,151 | 27,678 | 23.1% | 821.8% | 2,040,309 | 276,502 | 637.9% |
| 2022/08 | 207,200 | 30,766 | -40.5% | 573.5% | 1,785,158 | 248,824 | 617.4% |
| 2022/07 | 348,489 | 33,618 | 26% | 936.6% | 1,577,958 | 218,058 | 623.6% |
| 2022/06 | 276,669 | 24,620 | -20.4% | 1023.8% | 1,229,469 | 184,440 | 566.6% |
| 2022/05 | 347,722 | 32,168 | -1.6% | 981% | 952,800 | 159,820 | 496.2% |
| 2022/04 | 353,334 | 29,974 | 167.5% | 1078.8% | 605,078 | 127,652 | 374% |
| 2022/03 | 132,070 | 32,909 | 140% | 301.3% | 251,744 | 97,678 | 157.7% |
| 2022/02 | 55,023 | 33,675 | -14.9% | 63.4% | 119,674 | 64,769 | 84.8% |
| 2022/01 | 64,651 | 31,094 | -42.2% | 107.9% | 64,651 | 31,094 | 107.9% |
| 2021/12 | 111,793 | 38,472 | -50.4% | 190.6% | 656,043 | 560,550 | 17% |
| 2021/11 | 225,350 | 218,748 | 431.5% | 3% | 544,250 | 522,078 | 4.2% |
| 2021/10 | 42,398 | 38,318 | 53.2% | 10.6% | 318,900 | 303,330 | 5.1% |
| 2021/09 | 27,678 | 47,828 | -10% | -42.1% | 276,502 | 265,012 | 4.3% |
| 2021/08 | 30,766 | 39,194 | -8.5% | -21.5% | 248,824 | 217,184 | 14.6% |
| 2021/07 | 33,618 | 46,636 | 36.5% | -27.9% | 218,058 | 177,990 | 22.5% |
| 2021/06 | 24,620 | 46,108 | -23.5% | -46.6% | 184,440 | 131,354 | 40.4% |
| 2021/05 | 32,168 | 83,456 | 7.3% | -61.5% | 159,820 | 85,246 | 87.5% |
| 2021/04 | 29,974 | 1,080 | -8.9% | 2675.4% | 127,652 | 1,790 | 7031.4% |
| 2021/03 | 32,909 | 483 | -2.3% | 6713.5% | 97,678 | 710 | 13657.5% |
| 2021/02 | 33,675 | 95 | 8.3% | 35347.4% | 64,769 | 227 | 28432.6% |
| 2021/01 | 31,094 | 132 | -19.2% | 23456.1% | 31,094 | 132 | 23456.1% |
| 2020/12 | 38,472 | 199,226 | -82.4% | -80.7% | 560,550 | 305,692 | 83.4% |
| 2020/11 | 218,748 | 42 | 470.9% | 520728.6% | 522,078 | 106,466 | 390.4% |
| 2020/10 | 38,318 | 28 | -19.9% | 136750% | 303,330 | 106,424 | 185% |
| 2020/09 | 47,828 | 600 | 22% | 7871.3% | 265,012 | 106,396 | 149.1% |
藥華藥(6446) 歷年營收季增率
| 年度/季別 | 營收季增率 | 近4季營收季增率 | 年度/季別 | 營收季增率 | 近4季營收季增率 |
|---|---|---|---|---|---|
| 2023Q2 | 42.49% | 8.16% | 2020Q3 | 2.31% | 39.69% |
| 2023Q1 | 5.45% | 22.06% | 2020Q2 | 18300.56% | 22.70% |
| 2022Q4 | 3.81% | 19.10% | 2020Q1 | -99.64% | -11.39% |
| 2022Q3 | -17.07% | 42.25% | 2019Q4 | 11413.34% | 134.50% |
| 2022Q2 | 288.38% | 109.98% | 2019Q3 | -97.50% | 0.89% |
| 2022Q1 | -33.67% | 23.48% | 2019Q2 | 94.71% | 111.35% |
| 2021Q4 | 312.27% | 14.68% | 2019Q1 | 48.22% | 133.02% |
| 2021Q3 | 6.11% | -6.78% | 2018Q4 | 4017.01% | 598.32% |
| 2021Q2 | -11.18% | -6.67% | 2018Q3 | -45.91% | 1.65% |
| 2021Q1 | -66.95% | 17.30% | 2018Q2 | 74.39% | -9.41% |
| 2020Q4 | 121.12% | 20.73% | 2018Q1 | -58.37% | 1.12% |
評論0